Abstract:As a promising new form of non-apoptotic regulated cell death, ferroptosis has potential as an effective supplement to apoptosis-based cancer treatments. However, high intracellular glutathione (GSH) levels and insufficient hydrogen peroxide (H2O2) in the tumor limit the efficacy of ferroptosis. Here, we designed a theranostic nanoplatform, named FCS/GCS, by incorporating amphiphilic polymer skeletal (P-SS-D), cinnamaldehyde prodrug (CA-OH) and iron ions (Fe3+)/gadolinium ions (Gd3+) via chelation reactions between Fe3+/Gd3+ and polyphenols. When delivered in the tumor microenvironment with high GSH level, the nanoparticles are depolymerized by the poly(disulfide) backbone of P-SS-D. The activated CA consumes the GSH and elevates intracellular H2O2, followed by a high level of Fenton reaction to generate abundant •OH levels. The generation of reactive oxygen species (ROS) further accelerates CA activation. The GSH consumption by disulfide, CA and Fe3+, downregulates GPX4 and generates •OH, which accelerate lipid peroxides (LPO) accumulation and consequently enhances ferroptosis. Additionally, the released Gd3+ may serve as a contrast agent for tumor-specific T1-weighted magnetic resonance imaging (MRI). Thus, the rationally designed FCS/GCS system is a promising strategy for effective MRI-based visual ferroptosis therapy. STATEMENT OF SIGNIFICANCE: Ferroptosis is a new form of non-apoptotic regulated cell death and has potential as an effective supplement to apoptosis-based cancer treatment. However, the efficiency of ferroptosis is limited by excessive glutathione level and insufficient hydrogen peroxide level in tumor site. In this study, we fabricate a theranostic nanoplatform (FCS/GCS) to amplify oxidation stress in tumor site for effective ferroptosis-based cancer treatment, and tumor specific magnetic resonance imaging is introduced for supervision. Our nanoplatform may provide a promising strategy for MRI-based visual ferroptosis therapy with high specificity and efficiency.

Microenvironment‐differential Imaging of Demethylated Metabolites of Methionine for Identifying Ferroptosis Regional Preferences with Path‐independent Equifinal Fluorescence Probes

Endogenous molecule-targeted fluorescent probes for ferroptosis visualization: Current progress and future prospects

Multifunctional fluorescent probe for simultaneous revealing Cys and ONOO – dynamic correlation in the ferroptosis

In Situ and Quantitatively Monitoring the Dynamic Process of Ferroptosis in Single Cancer Cells by Scanning Electrochemical Microscopy

Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Recent advances in small-molecule fluorescent probes for studying ferroptosis

Fluorescent probes for ferroptosis bioimaging: advances, challenges, and prospects

NIR Fluorescent/Photoacoustic Bimodal Imaging of Ferroptosis in Pancreatic Cancer Using Biothiols-Activable Probes

A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis

Quantitative Profiling of Protein Carbonylations in Ferroptosis by an Aniline-Derived Probe.

Illuminating Cisplatin-induced Ferroptosis in Non-Small-Cell Lung Cancer with Biothiols-Activable Fluorescent/ Photoacoustic Bimodal Probes

A Nanozyme-Based Drug Delivery System to Amplify Ferroptosis Via MET Inhibition and Photodynamic Therapy

Reaction-Based Color-Convertible Fluorescent Probe for Ferroptosis Identification.

Recent advance in the development of the fluorescent responsive probes for the study of ferroptosis

Illuminating cisplatin-induced ferroptosis in non-small-cell lung cancer with biothiol-activatable fluorescent/photoacoustic bimodal probes

Metabolism-regulated ferroptosis in cancer progression and therapy

Identification of essential sites of lipid peroxidation in ferroptosis

Recent Advances of Fluorescence Probes for Imaging of Ferroptosis Process

Reactivity-Based Probe of the Iron(II)-Dependent Interactome Identifies New Cellular Modulators of Ferroptosis

Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy

Mechanosensitive fluorescence lifetime probes for investigating the dynamic mechanism of ferroptosis